Related references
Note: Only part of the references are listed.Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Circulating Tumor Cells and Circulating Tumor DNA
Catherine Alix-Panabieres et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance
David Tarin
CANCER AND METASTASIS REVIEWS (2012)
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Thomas Brabletz
CANCER CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells
Simon A. Joosse et al.
CLINICAL CANCER RESEARCH (2012)
Heparanase-Induced GEF-H1 Signaling Regulates the Cytoskeletal Dynamics of Brain Metastatic Breast Cancer Cells
Lon D. Ridgway et al.
MOLECULAR CANCER RESEARCH (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase
Lixin Zhang et al.
CANCER RESEARCH (2011)
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
Michal Mego et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer
Patricia M. McGowan et al.
MOLECULAR CANCER RESEARCH (2011)
A Novel Platform for Detection of CK+ and CK- CTCs
Chad V. Pecot et al.
CANCER DISCOVERY (2011)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
K. Ameri et al.
BRITISH JOURNAL OF CANCER (2010)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization-Based Case-Control Study
Ruth L. Katz et al.
CLINICAL CANCER RESEARCH (2010)
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epidermal Growth Factor-Induced Heparanase Nucleolar Localization Augments DNA Topoisomerase I Activity in Brain Metastatic Breast Cancer
Lixin Zhang et al.
MOLECULAR CANCER RESEARCH (2010)
Molecular mechanisms of metastasis in breast cancer-clinical applications
Michal Mego et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
Anieta M. Sieuwerts et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines
Paolo Romano et al.
NUCLEIC ACIDS RESEARCH (2009)
Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression
Victoria Cohen-Kaplan et al.
CANCER RESEARCH (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
HER2 status and benefit from adjuvant trastuzumab in breast cancer
Soonmyung Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Mammalian heparanase: what is the message?
Veronique Vreys et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
Diane Palmieri et al.
CANCER RESEARCH (2007)
Brain metastases: The HER2 paradigm
Nancy U. Lin et al.
CLINICAL CANCER RESEARCH (2007)
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ogechi N. Ikediobi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor
A Ostapkowicz et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
